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Abstract
Background: Several in vitro studies have looked at the effect of medicinal plant extracts against
Helicobacter pylori (H. pylori). Regardless of the popular use of Byrsonima crassa (B. crassa) as
antiemetic, diuretic, febrifuge, to treat diarrhea, gastritis and ulcers, there is no data on its effects
against H. pylori. In this study, we evaluated the anti-H. pylori of B. crassa leaves extracts and its
effects on reactive oxygen/nitrogen intermediates induction by murine peritoneal macrophages.
Methods: The minimal inhibitory concentration (MIC) was determined by broth microdilution
method and the production of hydrogen peroxide (H2O2) and nitric oxide (NO) by the horseradish
peroxidase-dependent oxidation of phenol red and Griess reaction, respectively.
Results: The methanolic (MeOH) and chloroformic (CHCl3) extracts inhibit, in vitro, the growth
of H. pylori with MIC value of 1024 μg/ml. The MeOH extract induced the production H2O2 and
NO, but CHCl3 extract only NO.
Conclusion: Based in our results, B. crassa can be considered a source of compounds with anti-
H. pylori activity, but its use should be done with caution in treatment of the gastritis and peptic
ulcers, since the reactive oxygen/nitrogen intermediates are involved in the pathogenesis of gastric
mucosal injury induced by ulcerogenic agents and H. pylori infections.
Background
Helicobacter pylori (H. pylori) is a spiral-shaped bacterium
that colonizes the stomach of the half of all people world-
wide [1]. Once a person is infected, the organism can live
in the stomach indefinitely and may not cause clinical ill-
ness. It is still not clear how H. pylori are transmitted or
why some people infected with its bacteria become sick
and others do not [2]. Studies have also shown an associ-
ation between long-term infection with H. pylori and the
development of gastric adenocarcinoma [3,4].
Therapy for H. pylori infection consists of 1–2 weeks of
one or two effective antibiotics, such as amoxicillin, tetra-
cycline, metronidazole, or clarithromycin, plus either ran-
itidine bismuth citrate, bismuth subsalicylate, or a proton
pump inhibitor [5]. Many clinical treatment trials involv-
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ing patients with H. pylori infection and gastric or duode-
nal ulcers show that curing the infection is associated with
a marked reduction in ulcer recurrence rates [6]. However,
eradication by the triple therapy is not always successful
and the acquisition by H. pylori resistant to antibiotics
could represent a serious problem that may reduce treat-
ment efficacy [7]. Considering that eradication therapies
can be ineffective and undesirable side effects may occur,
the search for new drugs for the development of alterna-
tive therapies is very important [1]. Plant extracts are
among the attractive sources of new drugs and have been
shown to produce promising results in the treatment of
gastric ulcers [8-11].
The genus Byrsonima, which is composed of approxi-
mately 150 species, belongs to the Malpighiaceae family
and is widely distributed throughout tropical America
[12,13]. This family is constituted by approximately 800
species distributed in 60 genera and about 50% of these
species are concentrated in Brazil [14]. In traditional Bra-
zilian medicine, Byrsonima crassa (B. crassa) is used as
antiemetic, diuretic, febrifuge, to treat diarrhea, gastritis
and ulcer [15].
The potential antiulcerogenic of B. crassa leaves extracts
were demonstrated by Sannomiya et al. [16]. The results of
this research showed that methanolic (MeOH) extract
provided better gastroprotective activity than chlorofor-
mic (CHCl3) extract. The presence of amentoflavone,
quercetin derivatives and catechins in the MeOH extract
were suggested to contribute for the gastroprotective activ-
ity since these compounds were reported to inhibit lipid
peroxidation as well as possess a very potent antioxidant
activity [16,17].
Several in vitro studies have looked at the effect of medic-
inal plant extracts against H. pylori [18-21]. This bacteria
induces inflammation, infiltration and activation of
immune cells, accumulation of reactive oxygen species,
and oxidative DNA damage in the gastric mucosa [22-24].
The antimicrobial compounds from plants may inhibit
bacterial growth by different mechanisms than those pres-
ently used antimicrobials, and could therefore be of clini-
cal value in the treatment of resistant microbial strains,
including H. pylori [25].
Despite of the popular use of B. crassa as a medicinal
plant, there is no data on its antimicrobial activity and
immunostimulatory effects. In this study, we evaluated, in
vitro, the anti-H. pylori of B. crassa leaves extracts (MeOH
and CHCl3) and its immunostimulatory effects in murine
immune system by determination of oxygen (H2O2) and
nitrogen (NO) intermediates reactive.
Methods
Plant material
B. crassa Nied. (Malpighiaceae) leaves were collected at
Porto Nacional, Tocantins State, Brazil and authenticated
by Prof. Eduardo Ribeiro dos Santos. A voucher specimen
(Nr. 3377) was deposited at the Herbarium of the
Tocantins University.
Extraction and preparation of extract solutions
The aerial parts (2.0 kg of leaves) obtained were dried (at
40°C for 4 days) and powdered. The dry powdered mate-
rial was macerated three times with 2 liters of chloroform
and methanol successively at room temperature and left
for 48 h in the respective solvent. The solvents were fil-
tered and evaporated at 60°C under reduced pressure pro-
viding CHCl3 (53.8 g) and MeOH (158.3 g) extracts. The
yields (w/w) for the CHCl3 and MeOH extracts from the
air-dried and powdered leaves of B. crassa leaves were 2.7
and 7.9%, respectively [16]. Stock solutions of plant
extracts (50 mg/ml) were prepared in dimethyl sulfoxide
(DMSO) and stored at -20°C. Dilutions of the stock solu-
tions were made in Brain Heart Infusion (BHI) plus 10%
fetal bovine serum (FBS) for antimicrobial activity and in
potassium phosphate buffer or RPMI-1640 medium for
measurement of H2O2 and NO production by peritoneal
macrophages. Fresh solutions were prepared for each
experiment.
Bacterial strain
H. pylori ATCC 43504, metronidazole resistant (MtzR)
and amoxicillin susceptible (AmxS), was obtained from
the American Type Culture Collection (Manassas, VA,
USA). The bacterium was cultured in Columbia agar con-
taining 5% sheep blood at 36–37°C for 3 days, in 5% O2,
10% CO2, 85% N2 atmosphere.
Antimicrobial activity
The wells of a 96-well microplate were filled with 100 μl
of various concentrations of the extracts. Same volume of
H. pylori suspension (about 106 cfu/ml) was added to each
well. The absorbance was determined using an automatic
ELISA microplate reader (Spectra & Rainbow Readers,
Tecan) adjusted at 620 nm. The microplate was incubated
at 36–37°C for 3 days, under microaerophilic atmos-
phere, agitated and the absorbance was read again in the
reader at the same wavelength. The absorbencies were
compared to the values obtained before incubation to
detect an increase in bacterial growth. The lowest concen-
tration of the test extract resulting in inhibition of bacte-
rial growth, at least, more than 90%, was taken as the
minimal inhibitory concentration (MIC). Amoxicillin
and metronidazole were used as reference antimicrobial.BMC Complementary and Alternative Medicine 2009, 9:2 http://www.biomedcentral.com/1472-6882/9/2
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Animals
Experiments involving Swiss mice (6–8 weeks old, 18 to
25 g) were performed in accordance with the regulations
of Research Ethics Committee (01/2005), Faculty of Phar-
maceutical Sciences, Unesp, São Paulo, Brazil.
Peritoneal macrophages
Resident and thioglycollate-elicited peritoneal exudate
cells were obtained from mice following intraperitoneal
injection of 3 ml thioglycollate medium (3.0 g/100 ml)
and lavage of the peritoneal cavity with 5 ml of 10 mM
phosphate-buffered saline (PBS), pH 7.2, 3–4 days later.
The proportion of macrophages in the peritoneal exudate
was determined by cell staining with May-Gruenwald-
Giemsa. Cell preparations contained more than 95% mac-
rophages. The cells were washed twice with PBS and resus-
pended in appropriate medium for each test.
Macrophages viability
For the determination of the concentrations of extracts
that do not cause cell death, the cytotoxic assay was per-
formed as described. Macrophages (106 cells/ml) were
suspended in RPMI-1640 containing 5% heat-inactivated
FBS, 100 IU/ml penicillin, 100 μg/ml streptomycin and
50 mM 2-mercaptoethanol. The suspension (100 μl) was
added to each well of a 96-well microplate and the cells
were incubated at 37°C in a humidified atmosphere con-
taining 5% CO2. After 1 h, the wells were washed and
adhering cells exposed to different concentrations of
methanolic or chloroformic extract for 1 and 24 h. The
test was accompanied by a viability positive control
(RPMI plus cells) and negative control (RPMI plus
extract). Finally, neutral red (NR) assay [26] was per-
formed and the absorbance at 540 nm (reference filter
620 nm) determined using an automatic microplate
reader.
Measurement of H2O2
Production H2O2 was measured by the horseradish perox-
idase (HRP)-dependent oxidation of phenol red [27].
Macrophages (2 × 106 cells/ml) were suspended in 10 mM
potassium phosphate buffer containing 140 mM NaCl,
5.5 mM dextrose, 0.56 mM phenol red and 0.01 mg/ml
HRP, pH 7.4. Briefly, 100 μl of this suspension was added
to each of a 96-well culture tissue plate and exposed to
methanolic and chloroformic extracts (concentrations of
extracts that do not cause cell death), for 1 h (time for the
H2O2 assay) at 37°C in a 5% CO2 atmosphere. The reac-
tion was stopped by the addition of 10 μl of 1 N NaOH
and the absorbances were read at 620 nm using a micro-
plate reader. The results are reported as nmol/2 × 105 cells.
The experiment was accompanied by a positive control
(buffer plus macrophages and 200 nM phorbol myristate
acetate, PMA) and negative control (buffer plus macro-
phages).
Measurement of NO
NO synthesis was determined by measuring the accumu-
lation of nitrite, a stable metabolite of NO, using the
Griess reaction [28]. Macrophages (100 μl) in at 5 × 106
cells/ml in RPMI containing 5% heat-inactivated FBS, 100
IU/ml penicillin, 100 μg/ml streptomycin and 50 mM 2-
mercaptoethanol, were added to each well of a 96-well
cell culture plate and exposed to methanolic and chloro-
formic extracts (concentrations that do not cause cell
death), for 24 h (time for the NO assay) at 37°C in a 5%
CO2 atmosphere. After incubation, 50 μl aliquots of cul-
ture supernatant were mixed with an equal volume of
Griess reagent and incubated at room temperature for 10
min. Absorbance at 540 nm was measured using a micro-
plate reader. The results are reported as μmol/5 × 105 cells.
Each experiment was accompanied by a positive control
(RPMI plus macrophages and 10 μg/ml lipopolysaccha-
ride, LPS) and a negative control (RPMI and macro-
phages).
Statistical Analysis
The results are expressed as means ± SD (Standard Devia-
tion). All tests were perform in triplicate and repeated at
least three times. Statistical difference between groups was
determined by one-way analysis of variance (ANOVA). A
p-value < 0.05 was considered statistically significant.
Results
The antibacterial activities of the extracts (MeOH and
CHCl3) from B. crassa against H. pylori, using spectropho-
tometer microdilution assay, are showed in Figure 1. The
results demonstrated that both MeOH and CHCl3 extract
exhibited anti-H. pylory activity with MIC value of 1024
μg/ml. The data presented in Figure 2 summarize the
release of H2O2 and NO by murine peritoneal macro-
phages. The MeOH extract at concentrations of 280 μg/ml
(maximum concentration that did not cause cell death)
was able to induce the release of 20.16 ± 0.58 nmol/2 ×
105 cells and 13.79 ± 2.58 μmol/5 × 105 cells H2O2 and
NO, respectively. The CHCl3 extract at concentration of
200 μg/ml (maximum concentration that did not cause
cell death) just induced the production of NO (8.63 ±
0.35 μmols/5 × 105 cells).
Discussion
Many anti-H. pylori compounds exhibiting a significant
inhibitory effect have been identified from plant materi-
als, among them flavonoids, tannins, terpenes, aromatic
aldehydes, alcohols, tannins and catechins [18,29-31].
Based on the popular use of B. crassa to treat gastritis and
ulcer, we investigated, in vitro, the susceptibility of H.
pylori ATCC 43504 (AmxS and MtzR strain) to MeOH and
CHCl3 extracts obtained from the leaves of this medicinal
plant. Both extracts presented MIC value of 1024 μg/ml.
In summary, our results suggest that B. crassa producesBMC Complementary and Alternative Medicine 2009, 9:2 http://www.biomedcentral.com/1472-6882/9/2
Page 4 of 7
(page number not for citation purposes)
Effect of the MeOH (A) and CHCl3 (B) extracts obtained of Byrsonima crassa on growth of Helicobacter pylori, following incuba- tion for 72 h Figure 1
Effect of the MeOH (A) and CHCl3 (B) extracts obtained of Byrsonima crassa on growth of Helicobacter pylori, 
following incubation for 72 h.
 
 
0
10
20
30
40
50
60
70
B
*
*
2
1
positive control negative control
N
O
 
p
r
o
d
u
n
t
i
o
n
 
(
μ
m
o
l
s
/
5
x
1
0
5
 
c
e
l
l
s
)
B. crassa extracts (μg/ml)
 
 
0 64 128 192 256 1024
0,00
0,02
0,04
0,06
0,08
0,10
A
A
b
s
o
r
b
a
n
c
e
 
(
6
2
0
 
n
m
)
B. crassa MeOH extract (Pg/ml)
0 64 128 192 256 1024
0,00
0,02
0,04
0,06
0,08
0,10
B
A
b
s
o
r
b
a
n
c
e
 
(
6
2
0
 
n
m
)
B. crassa CHCl3 extract (Pg/ml)BMC Complementary and Alternative Medicine 2009, 9:2 http://www.biomedcentral.com/1472-6882/9/2
Page 5 of 7
(page number not for citation purposes)
H2O2 (A) and NO (B) production from peritoneal macrophages stimulated with 280 μg/ml MeOH (1) and 200 μg/ml CHCl3 (2)  extracts Figure 2
H2O2 (A) and NO (B) production from peritoneal macrophages stimulated with 280 μg/ml MeOH (1) and 200 
μg/ml CHCl3 (2) extracts. Macrophages were exposed to Byrsonima crassa extracts for 1 h (A) and 24 h (B). The results are 
the mean ± SD of at least three independents experiments carried out in triplicate. *P < 0.05, significantly different from con-
trol without stimulating (negative control).
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secondary metabolites with anti-H. pylori activity. Proba-
bly, the antimicrobial activity demonstrated by extracts
may be due to the presence of polyphenolic compounds,
such as flavonoids, tannins, and terpenoids described in
the phytochemical profile of B. crassa [16,32,33], not dis-
carding the possibility of a synergistic effects between sub-
stances.
H. pylori infection has been associated with generation of
oxygen (ROS) and nitrogen (RNS) reactive species, which
leads to oxidative stress in gastric mucosa [22,34,35]. This
bacterium induces infiltration and activation of phago-
cytes, which produce inflammatory mediators, cytokines,
ROS and RNS. To avoid the negative effects of ROS, H.
pylori, like many other bacteria, produces enzymes
involved in ROS scavenging, such as catalase and superox-
ide dismutase. H. pylori also activates inducible nitric
oxide synthase in the gastric mucosa, which is associated
with epithelial cell injury and apoptosis [2]. No evidence
was found for a role of free radicals in the pathogenesis of
gastric mucosal injury in cases unrelated to H. pylori infec-
tion [35].
Macrophages are widely distributed in different tissues
and play an essential role in the development of the spe-
cific and nonspecific immune response. These cells can be
activated by a variety of stimuli as bacterial components,
cytokines and chemicals. Once activated, macrophages
produce and release numerous secretors products includ-
ing several cytokines, inorganic reactive radicals, reactive
oxygen intermediates (ROI) and reactive nitrogen inter-
mediates (RNI) with biological activities [36]. Hydrogen
peroxide (H2O2) and nitric oxide (NO) are important in
cell signaling and they are effectors molecules for micro-
bicidal and cytotoxic response of macrophages after stim-
ulation [37]. If ROI and RNI may be considered as
beneficial intermediates (with respect to its microbicidal
and tumoricidal activities), it also can become destructive
for the host tissue in certain conditions [38]. NO and reac-
tive oxygen species affect virtually every step of the devel-
opment of inflammation.
The immunomodulatory activity of several plants com-
pounds has already been described [39]. Davilla elliptica
chloroform extract triggered the production of H2O2, NO
and tumor necrosis factor-alpha in a dose-dependent
manner into cultured macrophages [40] whereas inhibi-
tory effects in H2O2 and NO production by ethyl acetate
fraction from Alchornea glandulosa were demonstrated
[41]. In particular, those plants that reduce the formation
of NO may be beneficial in pathophysiological conditions
where excessive production of NO is a contributory factor.
In this study, we demonstrated that extracts of B. crassa
induced the production H2O2 and NO. Agents that reduce
the formation of NO may be beneficial in H. pylori infec-
tions since an excessive production of NO is an agravating
factor in this condition. Finally, increased production of
free radicals has been demonstrated to occur during the
gastrointestinal metabolism of xenobiotics, which may
lead to intestinal disorders [42].
Despite of the antiulcerogenic effect exhibited by B. crassa
associated with HCl/ethanol induced gastric ulcers [16]
and inhibitory activity against H. pylori, an immunostim-
ulatory effect on the liberation of H2O2 and NO by B.
crassa leaves was demonstrated. Based in these results, B.
crassa can be considered a source of compounds with anti-
H. pylori activity, but its use should be done with caution
in treatment of the gastritis and peptic ulcers, since the
reactive oxygen/nitrogen intermediates are involved in the
pathogenesis of gastric mucosal injury induced ulcero-
genic agents and H. pylori infections.
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